This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Tretinoin (all-trans retinoic acid)
Tretinoin is the gold-standard topical retinoid since 1971, with A-tier evidence for acne (any concentration) and photoaging (Kligman…
Aliases (9)
Overview
What is Tretinoin (all-trans retinoic acid)?
Tretinoin (all-trans retinoic acid) is a topical retinoid FDA-approved for acne and photoaging, marketed as Retin-A and other brands. It is the gold-standard prescription topical for skin renewal, photoaging reversal, and inflammatory acne.
Key Benefits
Reduces acne (comedonal and inflammatory), reverses photoaging (fine lines, hyperpigmentation, texture), increases dermal collagen synthesis, and accelerates skin cell turnover. Long-term use is associated with measurable improvements in skin appearance.
Mechanism of Action
Binds nuclear retinoic acid receptors (RAR-α, RAR-β, RAR-γ), modulating gene transcription that controls keratinocyte differentiation, sebum production, and dermal extracellular matrix proteins. Increases collagen synthesis, normalizes follicular keratinization, and reduces melanogenesis.
Pharmacokinetics
▸ Application protocol Topical
- 1 Cleanse + dry skin. Pat skin dry; wait 15-20 min after washing for retinoids (reduces irritation). Skin must be fully dry — moisture amplifies penetration and irritation.
- 2 Pea-sized amount (or thin layer) for the entire treatment area. More is not better — irritation scales faster than efficacy.
- 3 Layering rules. Avoid combining with benzoyl peroxide (degrades retinoids), AHAs, or salicylic acid in the same routine. Niacinamide and ceramides are safe co-applications.
- 4 Sunscreen mandatory next AM. Most topicals (especially retinoids, hydroquinone) increase photosensitivity. SPF 30+ broad-spectrum minimum.
- 5 Ramp slowly. Start every-other-night for 2-4 weeks; increase to nightly only after tolerance builds. Skipping a night during peak irritation is the right move.
No systemic dosing required — topicals act locally with minimal serum absorption at standard doses.
Research Indications
RAR-α
broadly expressed
RAR-β
modulated in differentiation
RAR-γ
*the predominant isoform in epidermis* (~90% of epidermal RAR), the main mechanism for tretinoin's keratinocyte effects
Research Protocols
Disclaimer: These are commonly discussed research protocols and not medical advice.
Peptide Interactions
reduces tretinoin irritation, restores barrier, complementary anti-pigmentation. Apply niacinamide AM, tretinoin PM (or layer with niacinamide first if combi…
synergistic anti-photoaging — vitamin C drives collagen crosslinking (lysyl oxidase cofactor), tretinoin drives collagen transcription. Apply vitamin C AM, t…
complementary mechanism (signal-side collagen + barrier repair vs tretinoin's transcription effects). Apply GHK-Cu AM, tretinoin PM (timing-separated). The 2…
simple humectant layer; reduces tretinoin dryness without efficacy loss.
anti-inflammatory + anti-comedonal + brightening; gentler partner with tretinoin; can alternate nights.
acne combination protocols.
for moderate-severe inflammatory acne, paired with topical tretinoin.
BPO oxidizes/deactivates tretinoin → loss of efficacy. Solution: BPO in AM, tretinoin in PM, OR use tretinoin microsphere (Retin-A Micro), which is BPO-stabl…
compound irritation. Use on alternate nights or separate AM/PM.
fine in Kligman's triple-combination protocol (8-12 weeks). Avoid chronic indefinite combination; risk of ochronosis with prolonged hydroquinone.
pause tretinoin 5-7 days before; risk of skin tearing.
pause tretinoin 5-7 days before and after.
Quality Indicators
Stable cream/serum base
Should have a uniform texture, no separation, no off odor.
Color drift
Some actives oxidize when exposed to air or light; minor color shift can be normal.
Separation or off smell
Phase separation, mold, or strong rancid odor indicates degraded product — discard.
What to Expect
- Week 1-2Application protocol established. Watch for irritation.
- Week 4Early visible/measurable change. Most topicals are slow.
- Week 8-12Meaningful effect window for most topical actives.
- Month 6+Maintenance phase. Stopping reverses gains over weeks-months.
Side Effects & Safety 10
Side Effects
- 1Erythema — mild-to-moderate redness
- 2Scaling, peeling, dryness — most prominent first 4-6 weeks
- 3Stinging or burning on application — reduces with tolerance
- 4Initial acne purge — week 2-6 (mechanism-correct; resolves)
- 5Photosensitivity — mechanistic; AM SPF mandatory
- 6Pruritus — mild itching during retinization
- 7Persistent irritation beyond week 8 — reduce frequency, lower concentration, increase moisturizer buffering
- 8Hyperpigmentation in skin of color from over-irritation — be more conservative with titration in Fitzpatrick IV-VI
- 9Hypopigmentation (rare; usually transient)
- 10Worsening of pre-existing eczema, rosacea, or perioral dermatitis ← *the user flag*
When to Stop
- Severe contact dermatitis / sensitization — discontinue
- Precipitation or major flare of perioral/periorificial dermatitis ← *the archetype-specific risk*
- Paradoxical acne worsening if overused (chronic irritation → barrier compromise → microbial dysbiosis → more acne)
- Eye irritation if applied too close to eyes; avoid periorbital application without specific indication
- Pregnancy: ABSOLUTE CONTRAINDICATION (Category C; some sources Category D for the related etretinate / acitretin oral retinoids, but topical tretinoin in pregnancy is also contraindicated by FDA labeling). Topical absorption is low (~2%) but the safety margin is too thin given retinoids' known teratogenicity. Discontinue 1 month before planned conception.
- Active perioral dermatitis, rosacea flare, severe eczema — relative contraindication; pursue underlying-condition treatment first
- Recent IPL, laser resurfacing, chemical peels, dermabrasion, waxing of treated area — pause tretinoin 5-7 days before/after; combination → severe irritation
- Sunburn / acute UV damage — pause until resolved
- Weeks 1-4: monitor for excessive irritation; should be tolerable, not painful. If painful, reduce to 1×/week or switch to adapalene.
- Weeks 4-8: purge phase. Differentiate "purge" (small comedones surfacing) from "POD precipitation" (red papules + scaling around mouth/nose/eyes — NOT comedones).
- Months 3-6: assess benefit/tolerability balance. Adjust concentration or frequency.
- Long-term: continued use is fine; barrier function should be normal once tolerized.
References
Kligman AM et al. *Topical tretinoin for photoaged skin.* J Am Acad Dermatol 1986
original photoaging RCT
View StudyWeinstein GD et al. *Topical tretinoin for treatment of photodamaged skin: a multicenter study.* Arch Dermatol 1991
confirmatory multicenter trial
View StudyCochrane review: topical retinoids for acne vulgaris
meta-analysis of retinoid efficacy
View StudyAmerican Academy of Dermatology — Acne Guidelines 2024
first-line topical retinoid recommendation
View StudyTolaymat L, Hall MR. *Perioral Dermatitis.* StatPearls 2023
POD pathogenesis + management; lists topical retinoids as triggers
View StudyKang S et al. *Mechanism of retinol-induced epidermal hyperplasia.* J Invest Dermatol 1995
mechanism of retinoid epidermal effects
View StudyFDA Renova prescribing information
1995 FDA approval for photodamage
View StudyKligman's triple-combination cream (Tri-Luma) prescribing info
melasma combination protocol
View StudyCurology / Apostrophe / Hers compounded tretinoin services
telehealth Rx pathway
View StudyHow was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.